Company profile for Lantheus Holding

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lantheus has been instrumental in pioneering the field of medical imaging. For 60 years, we have helped physicians enhance patient care with our broad product portfolio of imaging agents and products that illuminate the heart, brain, lungs and other organs. At Lantheus, we are committed to helping healthcare professionals identify disease and improve patient care by providing essential diagnostic imaging agents and products. O...
Lantheus has been instrumental in pioneering the field of medical imaging. For 60 years, we have helped physicians enhance patient care with our broad product portfolio of imaging agents and products that illuminate the heart, brain, lungs and other organs. At Lantheus, we are committed to helping healthcare professionals identify disease and improve patient care by providing essential diagnostic imaging agents and products. Our commitment to making a difference extends beyond our work in the medical imaging field. Supporting organizations where our employees live and work is an important part of what we do.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Lantheus Medical Imaging 331 Treble Cove Rd. N. Billerica, MA 01862
Telephone
Telephone
1-800-362-2668
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/20/3169263/0/en/Radiopharm-Theranostics-completes-A-35-million-Placement-and-launches-a-A-5-million-Share-Purchase-Plan.html

GLOBENEWSWIRE
20 Oct 2025

https://www.prnewswire.com/news-releases/cytosite-bio-announces-agreement-with-lantheus-for-granzyme-b-targeted-pet-imaging-radiotracer-for-immunotherapy-assessment-302412492.html

PR NEWSWIRE
26 Mar 2025

https://www.prnewswire.com/news-releases/lantheus-to-acquire-evergreen-theragnostics-for-upfront-payment-of-250-million-to-drive-strategic-evolution-into-fully-integrated-radiopharmaceutical-leader-302361401.html

PR NEWSWIRE
28 Jan 2025

https://www.globenewswire.com/news-release/2025/01/10/3007645/0/en/Lantheus-Increases-to-12-16-shareholding-in-Radiopharm-with-US-5m-A-8m-Placement.html

GLOBENEWSWIRE
10 Jan 2025

https://www.fiercebiotech.com/biotech/esmo-lantheus-phase-3-radiotherapy-readout-not-enough-topple-pluvicto-say-analysts

FIERCE BIOTECH
16 Sep 2024
Lantheus Announces CEO Succession Plan
Lantheus Announces CEO Succession Plan

23 Jan 2024

// PRESS RELEASE

https://lantheusholdings.gcs-web.com/news-releases/news-release-details/lantheus-announces-ceo-succession-plan

PRESS RELEASE
23 Jan 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty